Mometasone PCD Pharma Franchise Company
Cafoli Lifecare offers 8 Mometasone formulations across cream and nasal spray, serving both the dermatology and ENT segments. All products are made at WHO-GMP certified facilities and offered to franchise partners with monopoly rights.
What is Mometasone?
Mometasone furoate is a potent synthetic corticosteroid with high topical anti-inflammatory activity and low systemic absorption. It suppresses the inflammatory response in skin and nasal mucosa by reducing inflammatory mediator release. Details are available on MedlinePlus.
Therapeutic Applications
Topical Mometasone cream is used for eczema, atopic dermatitis, psoriasis and other corticosteroid-responsive skin conditions. Mometasone nasal spray is used for allergic rhinitis and nasal polyps. Prescribers include dermatologists, ENT specialists, allergists, paediatricians and general physicians.
Why Mometasone is a High-Potential Molecule for Distributors
Mometasone lets a partner monetise one molecule across two different doctor call lists — derma and ENT — without expanding the portfolio. Allergic rhinitis affects a large share of India's urban population and intranasal steroids are first-line therapy, so the nasal spray generates dependable, seasonally reinforced repeat demand.
Why Choose Cafoli Lifecare
We offer district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, attractive net rates and complete promotional inputs, backed by 1000+ franchise partners.
References
- MedlinePlus: Mometasone (topical)
- PubChem: Mometasone Furoate
Our formulations of Mometasone find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: